FDA approves first AI test to guide breast cancer chemotherapy decisions

Summary: The FDA just approved a new AI tool called ArteraAI Breast. It helps doctors figure out if patients with early-stage breast cancer really need chemotherapy. By looking at digital images of tumor tissue, the AI predicts the chance of the cancer spreading. This is a huge deal because it can spare many women from the harsh, toxic side effects of chemo if they don't actually need it. Doctors are excited because it offers a faster, personalized way to treat breast cancer without the guesswork.

For more details, see rssapp-medicalnewstoday-com at medicalnewstoday.com/articles/fda-approves-first-ai-test-guide-breast-cancer-patients-chemotherapy (opens in new tab)